TY - JOUR
T1 - Physiological factors contributing to HbA1c in the normal and pre-diabetic range
T2 - a cross-sectional analysis
AU - Bruhn, Lea
AU - Vistisen, Dorte
AU - Vainø, Camilla Trine Ravn
AU - Perreault, Leigh
AU - Færch, Kristine
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Purpose: Little is known about the underlying physiology that contributes to Haemoglobin A1c (HbA
1c) in the normal and pre-diabetic range. We determined the contribution of fasting plasma glucose (FPG), 2-h plasma glucose (2hPG), insulin secretion, insulin sensitivity and endogenous glucose production to HbA
1c levels in the normal and pre-diabetic range. Methods: A total of 62 Danish men and women with normal or impaired glucose regulation were studied. HbA
1c levels were measured and participants underwent an oral glucose tolerance test with measurements of FPG and 2hPG, an intravenous glucose tolerance test for determination of first-phase insulin release, and a hyperinsulinaemic euglycaemic clamp for estimation of peripheral and hepatic insulin sensitivity. Associations of HbA
1c with the different measures of glucose metabolism were analysed by linear regression analysis. Results: HbA
1c levels ranged from 28 to 45 mmol/mol (4.7–6.3%) in the study population. 1 SD higher (log) FPG concentration (~1 mmol/L) was associated with 2 mmol/mol higher HbA
1c concentration (P < 0.001). In comparison, 1 SD higher levels of (log) first-phase insulin secretion or (log) disposition index were associated with 1.5 mmol/mol lower HbA
1c levels (P < 0.05). HbA
1c was not associated with peripheral or hepatic insulin sensitivity, endogenous glucose production or 2hPG levels. Conclusion: HbA
1c levels within the normal and pre-diabetic range seem to reflect decreased insulin secretion to a higher extent than insulin resistance. Therefore, early prevention strategies for high-risk individuals identified by HbA
1c are not straightforward. More research on how to improve the health of beta cells either directly or indirectly in high-risk individuals is needed.
AB - Purpose: Little is known about the underlying physiology that contributes to Haemoglobin A1c (HbA
1c) in the normal and pre-diabetic range. We determined the contribution of fasting plasma glucose (FPG), 2-h plasma glucose (2hPG), insulin secretion, insulin sensitivity and endogenous glucose production to HbA
1c levels in the normal and pre-diabetic range. Methods: A total of 62 Danish men and women with normal or impaired glucose regulation were studied. HbA
1c levels were measured and participants underwent an oral glucose tolerance test with measurements of FPG and 2hPG, an intravenous glucose tolerance test for determination of first-phase insulin release, and a hyperinsulinaemic euglycaemic clamp for estimation of peripheral and hepatic insulin sensitivity. Associations of HbA
1c with the different measures of glucose metabolism were analysed by linear regression analysis. Results: HbA
1c levels ranged from 28 to 45 mmol/mol (4.7–6.3%) in the study population. 1 SD higher (log) FPG concentration (~1 mmol/L) was associated with 2 mmol/mol higher HbA
1c concentration (P < 0.001). In comparison, 1 SD higher levels of (log) first-phase insulin secretion or (log) disposition index were associated with 1.5 mmol/mol lower HbA
1c levels (P < 0.05). HbA
1c was not associated with peripheral or hepatic insulin sensitivity, endogenous glucose production or 2hPG levels. Conclusion: HbA
1c levels within the normal and pre-diabetic range seem to reflect decreased insulin secretion to a higher extent than insulin resistance. Therefore, early prevention strategies for high-risk individuals identified by HbA
1c are not straightforward. More research on how to improve the health of beta cells either directly or indirectly in high-risk individuals is needed.
KW - 2-h plasma glucose (2hPG)
KW - Fasting plasma glucose (FPG)
KW - Haemoglobin A1c (HbA )
KW - Insulin secretion
KW - Insulin sensitivity
KW - Pre-diabetes
UR - http://www.scopus.com/inward/record.url?scp=85081358629&partnerID=8YFLogxK
U2 - 10.1007/s12020-020-02234-3
DO - 10.1007/s12020-020-02234-3
M3 - Journal article
C2 - 32112239
SN - 1355-008X
VL - 68
SP - 306
EP - 311
JO - Endocrine
JF - Endocrine
IS - 2
ER -